COLGATE PALMOLIVE CO
CLAPI behind this page
CL FY 2025 request
Playground key active
/api/financials?ticker=CL&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 20,382 | 20,101 | +1.4% |
Show Business Segments breakouts |
|||
| Pet Nutrition · Operating Segments | 4,613 | 4,483 | +2.9% |
| Pet Nutrition · US | 3,062 | 3,059 | +0.1% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 1,172 | 1,095 | +7.0% |
| Total Oral, Personal and Home Care · Asia Pacific | 2,814 | 2,858 | -1.5% |
| Total Oral, Personal and Home Care · Europe | 2,962 | 2,770 | +6.9% |
| Total Oral, Personal and Home Care · Latin America | 4,776 | 4,782 | -0.1% |
| Total Oral, Personal and Home Care · North America | 4,045 | 4,113 | -1.7% |
| Total Oral, Personal and Home Care · Operating Segments | 15,769 | 15,618 | +1.0% |
| Total Oral, Personal and Home Care · US | 3,596 | 3,640 | -1.2% |
| Cost of Revenue | 8,131 | 7,940 | +2.4% |
Show Business Segments breakouts |
|||
| Pet Nutrition · Operating Segments | 1,818 | 1,869 | -2.7% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 465 | 432 | +7.6% |
| Total Oral, Personal and Home Care · Asia Pacific | 1,067 | 1,078 | -1.0% |
| Total Oral, Personal and Home Care · Europe | 1,099 | 1,050 | +4.7% |
| Total Oral, Personal and Home Care · Latin America | 2,107 | 1,933 | +9.0% |
| Total Oral, Personal and Home Care · North America | 1,589 | 1,571 | +1.1% |
| Gross Profit | 12,251 | 12,161 | +0.7% |
| Selling, General & Administrative | 7,903 | 7,729 | +2.3% |
Show Product Lines breakouts |
|||
| Shipping And Handling | 1,789 | 1,777 | +0.7% |
Show Business Segments breakouts |
|||
| Pet Nutrition · Operating Segments | 1,717 | 1,641 | +4.6% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 436 | 395 | +10.4% |
| Total Oral, Personal and Home Care · Asia Pacific | 1,013 | 997 | +1.6% |
| Total Oral, Personal and Home Care · Europe | 1,087 | 1,031 | +5.4% |
| Total Oral, Personal and Home Care · Latin America | 1,268 | 1,328 | -4.5% |
| Total Oral, Personal and Home Care · North America | 1,626 | 1,668 | -2.5% |
| Other Operating Income Expense Net | 123 | 164 | -25.0% |
| Goodwill And Intangible Asset Impairment | 919 | — | — |
| Operating Income | 3,306 | 4,268 | -22.5% |
Show Business Segments breakouts |
|||
| Pet Nutrition · Operating Segments | 1,064 | 965 | +10.3% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 255 | 253 | +0.8% |
| Total Oral, Personal and Home Care · Asia Pacific | 760 | 812 | -6.4% |
| Total Oral, Personal and Home Care · Europe | 748 | 658 | +13.7% |
| Total Oral, Personal and Home Care · Latin America | 1,411 | 1,526 | -7.5% |
| Total Oral, Personal and Home Care · North America | 784 | 839 | -6.6% |
| Total Oral, Personal and Home Care · Operating Segments | 3,959 | 4,088 | -3.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,717 | -784 | -119.0% |
| Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component | 55 | 87 | -36.8% |
| Interest Expense | 267 | 292 | -8.6% |
| Interest Income | 75 | 67 | +11.9% |
| Income Before Taxes | 3,059 | 3,956 | -22.7% |
| Income Tax Expense (Benefit) | 798 | 907 | -12.0% |
| Net Income | 2,261 | 3,049 | -25.8% |
| Net Income Loss Attributable To Noncontrolling Interest | 129 | 160 | -19.4% |
| Net Income | 2,132 | 2,889 | -26.2% |
| EPS (Basic) | 2.64 | 3.53 | -25.2% |
| EPS (Diluted) | 2.63 | 3.51 | -25.1% |
| Research & Development | 366 | 355 | +3.1% |
| Comprehensive Income | 2,474 | 2,605 | -5.0% |
| Wtd Avg Shares (Basic) | 808.7 | 819.1 | -1.3% |
| Wtd Avg Shares (Diluted) | 811.1 | 823.2 | -1.5% |
| Net Income Loss Available To Common Stockholders Basic | 2,132 | 2,889 | -26.2% |
| Income Loss From Equity Method Investments | -20 | -22 | +9.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,288 | 1,096 | +17.5% |
| Accounts Receivable | 1,675 | 1,521 | +10.1% |
| Inventory | 2,032 | 1,987 | +2.3% |
| Other Assets Current | 714 | 713 | +0.1% |
| Total Current Assets | 5,709 | 5,317 | +7.4% |
| Marketable Securities (Current) | 107 | 160 | -33.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,660 | 4,422 | +5.4% |
| Goodwill | 3,122 | 3,272 | -4.6% |
Show Business Segments breakouts |
|||
| Pet Nutrition | 706 | 482 | +46.5% |
| Total Oral, Personal and Home Care | 2,416 | 2,790 | -13.4% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 82 | 78 | +5.1% |
| Total Oral, Personal and Home Care · Asia Pacific | 185 | 178 | +3.9% |
| Total Oral, Personal and Home Care · Europe | 1,430 | 1,281 | +11.6% |
| Total Oral, Personal and Home Care · Latin America | 161 | 145 | +11.0% |
| Total Oral, Personal and Home Care · North America | 558 | 1,108 | -49.6% |
Show Reporting Unit breakouts |
|||
| Filorga Reporting Unit | 51 | — | — |
| Deferred Tax Assets | 205 | 195 | +5.1% |
| Other Non-Current Assets | 1,098 | 1,084 | +1.3% |
| Total Assets | 16,330 | 16,046 | +1.8% |
| Operating Lease Right-of-Use Assets | 531 | 529 | +0.4% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Other Intangible Assets | 129 | 218 | -40.8% |
| Trademarks | 380 | 590 | -35.6% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 1,536 | 1,756 | -12.5% |
Show Indefinite Lived Intangible Assets By Major Class breakouts |
|||
| Unclassified Indefinitelived Intangible Assets | 1,027 | 948 | +8.3% |
| Current Liabilities | |||
| Short Term Bank Loans And Notes Payable | 1,117 | 660 | +69.2% |
| Accounts Payable | 2,089 | 1,805 | +15.7% |
| Accrued Income Taxes Current | 383 | 403 | -5.0% |
| Other Accrued Liabilities Current | 3,264 | 2,891 | +12.9% |
| Total Current Liabilities | 6,853 | 5,759 | +19.0% |
| Current Portion of Long-Term Debt | 1,115 | 652 | +71.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 6,871 | 7,289 | -5.7% |
| Deferred Tax Liabilities | 181 | 343 | -47.2% |
| Other Non-Current Liabilities | 2,060 | 2,111 | -2.4% |
| Total Liabilities | 15,965 | 15,502 | +3.0% |
| Long-Term Debt | 7,839 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 7,988 | 7,949 | +0.5% |
| Operating Lease Liabilities | 448 | 456 | -1.8% |
| Stockholders' Equity | |||
| Common Stock | 1,466 | 1,466 | 0.0% |
| Additional Paid-In Capital | 4,322 | 4,181 | +3.4% |
| Retained Earnings | 26,595 | 26,145 | +1.7% |
| Accumulated Other Comprehensive Income | -3,879 | -4,222 | +8.1% |
| Treasury Stock Common Value | -28,450 | -27,358 | -4.0% |
| Total Stockholders' Equity | 54 | 212 | -74.5% |
| Minority Interest | 311 | 332 | -6.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 365 | 544 | -32.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -3,879 | -4,222 | +8.1% |
| Additional Paid In Capital | 4,322 | 4,181 | +3.4% |
| Common Stock | 1,466 | 1,466 | 0.0% |
| Noncontrolling Interest | 311 | 332 | -6.3% |
| Retained Earnings | 26,595 | 26,145 | +1.7% |
| Treasury Stock Common | -28,450 | -27,358 | -4.0% |
| Total Liabilities & Equity | 16,330 | 16,046 | +1.8% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 630 | 605 | +4.1% |
Show Business Segments breakouts |
|||
| Pet Nutrition · Operating Segments | 144 | 132 | +9.1% |
| Total Oral, Personal and Home Care · Africa/Eurasia | 10 | 8 | +25.0% |
| Total Oral, Personal and Home Care · Asia Pacific | 80 | 81 | -1.2% |
| Total Oral, Personal and Home Care · Europe | 66 | 65 | +1.5% |
| Total Oral, Personal and Home Care · Latin America | 106 | 100 | +6.0% |
| Total Oral, Personal and Home Care · North America | 123 | 124 | -0.8% |
| Total Oral, Personal and Home Care · Operating Segments | 385 | 378 | +1.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 101 | 95 | +6.3% |
| Litigation Settlement Expense | 65 | — | — |
Show Retirement Plan Type breakouts |
|||
| Pension Plans Defined Benefit · ERISA | 65 | — | — |
| Pension Plans Defined Benefit · US | -34 | — | — |
| Restructuring Net Of Cash | -7 | 51 | -113.7% |
| Stock-Based Compensation | 155 | 135 | +14.8% |
| Deferred Income Taxes And Tax Credits | -109 | -77 | -41.6% |
| Increase Decrease In Receivables | -16 | -56 | +71.4% |
| Change in Inventory | 109 | -100 | +209.0% |
| Increase Decrease In Accounts Payable And Other Working Capital | 251 | 516 | -51.4% |
| Increase Decrease In Other Noncurrent Assets | 35 | 28 | +25.0% |
| Change in Other Liabilities | -95 | -44 | -115.9% |
| Net Cash from Operations | 4,198 | 4,107 | +2.2% |
| Deferred Income Taxes | 156 | 33 | +372.7% |
| Investing Activities | |||
| Payments To Acquire Productive Assets | -564 | -561 | -0.5% |
| Payments To Acquire Marketable Securities | -698 | -574 | -21.6% |
| Proceeds From Sale And Maturity Of Marketable Securities | 752 | 564 | +33.3% |
| Payments To Acquire Businesses Net Of Cash Acquired | -293 | — | — |
| Other Investing Activities | -14 | 37 | -137.8% |
| Net Cash from Investing | -817 | -534 | -53.0% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | -989 | 93 | -1163.4% |
| Repayments Of Other Debt | -655 | -503 | -30.2% |
| Proceeds From Other Debt | 1,188 | 2 | +59300.0% |
| Payments Of Ordinary Dividends | -1,823 | -1,789 | -1.9% |
| Share Repurchases | -1,210 | -1,739 | +30.4% |
| Proceeds From Stock Options Exercised | 101 | 638 | -84.2% |
| Proceeds From Payments For Other Financing Activities | 132 | -91 | +245.1% |
| Net Cash from Financing | -3,256 | -3,389 | +3.9% |
| Supplemental | |||
| Income Taxes Paid | 913 | 933 | -2.1% |
| Interest Paid | 270 | 302 | -10.6% |
| Income Taxes Paid | 913 | — | — |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 67 | -54 | +224.1% |
| Net Change in Cash | 192 | 130 | +47.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,288 | 1,096 | +17.5% |
Values in millions USD. Source: SEC EDGAR 10-K filing.